Cargando…
Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
In carcinoma of prostate, a causative role of platelet 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) for tumor progression has been firmly established in tumor and/or adjacent tissue. Our goal was to investigate if 12-LOX and/or PAI-1 in patient's plasma could be used t...
Autores principales: | Gondek, Tomasz, Szajewski, Mariusz, Szefel, Jarosław, Aleksandrowicz-Wrona, Ewa, Skrzypczak-Jankun, Ewa, Jankun, Jerzy, Lysiak-Szydlowska, Wieslawa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982265/ https://www.ncbi.nlm.nih.gov/pubmed/24783193 http://dx.doi.org/10.1155/2014/102478 |
Ejemplares similares
-
The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostate
por: Piotrowska, Małgorzata, et al.
Publicado: (2013) -
Medium-chain triglycerides/long-chain triglycerides versus long-chain triglycerides in treatment of cancer patients with major body mass loss. Survival in patients with refractory cachexia
por: Szefel, Jarosław, et al.
Publicado: (2016) -
Can components of the plasminogen activation system predict the outcome of kidney transplants?
por: Jankun, Jerzy, et al.
Publicado: (2018) -
Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives
por: PARSAI, SHIREEN, et al.
Publicado: (2014) -
Isolation and characterization of serum albumin from Camelus dromedarius
por: MALIK, AJAMALUDDIN, et al.
Publicado: (2013)